Want to see IN:MEDPLUS full AI Analyst Report?
MEDPLUS Stock Chart & Stats
₹808.80
₹1.40(0.17%)
At close: 4:00 PM EST
₹808.80
₹1.40(0.17%)
Day’s Range― - ―
52-Week Range₹653.80 - ₹1,020.35
Previous CloseN/A
Volume104.47K
Average Volume (3M)39.52K
Market Cap
₹84.69B
Enterprise Value₹108.84K
Total Cash (Recent Filing)₹4.62B
Total Debt (Recent Filing)₹14.24B
Price to Earnings (P/E)40.2
Beta0.53
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)18.33
Shares Outstanding120,137,060
10 Day Avg. Volume11,750
30 Day Avg. Volume39,524
Financial Highlights & Ratios
PEG Ratio1.00
Price to Book (P/B)5.10
Price to Sales (P/S)1.46
P/FCF Ratio24.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)18.13
Revenue Forecast (FY)₹80.52B
Bulls Say, Bears Say
Bulls Say
Omnichannel Retail ModelA combined neighborhood retail footprint plus digital ordering and home delivery creates durable customer convenience and repeat prescription flows. This omnichannel model supports higher reach, better inventory turnover and cross-sell, helping sustain revenue per customer and competitive positioning over time.
Consistent Revenue ScalingMulti-year top-line growth indicates successful store expansion and market penetration. Consistent revenue scaling provides operating leverage potential and supports investment in logistics and procurement, making future margin improvement and service expansion more achievable across the next several quarters.
Improved Cash GenerationA clear rebound to positive OCF and FCF provides financial flexibility for reinvestment, network expansion, and debt servicing. Sustained free cash flow reduces dependence on external financing and underpins capacity to fund omnichannel operations and capex over the medium term.
Bears Say
Thin And Volatile MarginsVery low net margins limit the buffer against cost inflation or pricing pressure and make earnings sensitive to small revenue or cost swings. A sharp gross-margin decline in 2026 suggests structural mix or procurement pressures that, if persistent, could materially compress long-term profitability.
Rising LeverageIncreasing leverage raises financial risk for a thin-margin retailer, constraining flexibility for price competition or incremental investment. Higher debt levels increase interest and refinancing exposure, reducing resilience to macro shocks and limiting capital allocation options in the medium term.
Inconsistent Cash ConversionSub‑par cash conversion and reliance on working‑capital dynamics create variability in available cash for reinvestment or deleveraging. Even with recent FCF gains, inconsistent conversion raises the risk that growth or margin pressures will strain liquidity when capex, inventory or supplier terms shift.
MedPlus Health Services Ltd. News
MEDPLUS FAQ
What was MedPlus Health Services Ltd.’s price range in the past 12 months?
MedPlus Health Services Ltd. lowest stock price was ₹653.80 and its highest was ₹1020.35 in the past 12 months.
What is MedPlus Health Services Ltd.’s market cap?
MedPlus Health Services Ltd.’s market cap is ₹84.69B.
When is MedPlus Health Services Ltd.’s upcoming earnings report date?
MedPlus Health Services Ltd.’s upcoming earnings report date is Nov 05, 2026 which is in 93 days.
How were MedPlus Health Services Ltd.’s earnings last quarter?
MedPlus Health Services Ltd. released its earnings results on Jul 21, 2026. The company reported ₹2.8 earnings per share for the quarter, beating the consensus estimate of ₹1.95 by ₹0.85.
Is MedPlus Health Services Ltd. overvalued?
According to Wall Street analysts MedPlus Health Services Ltd.’s price is currently Overvalued.
Does MedPlus Health Services Ltd. pay dividends?
MedPlus Health Services Ltd. does not currently pay dividends.
What is MedPlus Health Services Ltd.’s EPS estimate?
MedPlus Health Services Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MedPlus Health Services Ltd. have?
MedPlus Health Services Ltd. has 120,137,060 shares outstanding.
What happened to MedPlus Health Services Ltd.’s price movement after its last earnings report?
MedPlus Health Services Ltd. reported an EPS of ₹2.8 in its last earnings report, beating expectations of ₹1.95. Following the earnings report the stock price went down -0.693%.
Which hedge fund is a major shareholder of MedPlus Health Services Ltd.?
Currently, no hedge funds are holding shares in IN:MEDPLUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MedPlus Health Services Ltd.
MedPlus Health Services Limited operates primarily as an Indian retailer of pharmaceutical products and diverse general merchandise. Its extensive product catalog includes vital health and wellness items such as prescription medications, vitamins, medical equipment, and diagnostic kits, alongside everyday essentials like toiletries, baby care products, cleaning supplies, and sanitizers. Beyond its retail footprint, the company also offers wholesale cash-and-carry services, comprehensive pathological laboratory testing, and contract manufacturing for its own-brand pharmaceutical goods. By March 31, 2021, MedPlus had established a substantial presence with 1,659 brick-and-mortar stores situated in the Indian states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, complemented by its online store. This Hyderabad-based company was incorporated in 2006.
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Sastasundar Ventures Limited
―
Thyrocare Technologies Ltd
―